Advances in Multiple Myeloma Imaging in 2025

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".

Deadline for manuscript submissions: 31 August 2025 | Viewed by 701

Special Issue Editor


E-Mail Website
Guest Editor
Department of Radiology, Division of Musculoskeletal Imaging and Intervention, University of Washington, Seattle, WA 98195, USA
Interests: radiology; imaging; musculoskeletal radiology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Multiple myeloma (MM) remains a debilitating disease despite recent advances in diagnosis and treatment, with a 1:150 lifetime risk, higher incidences in elderly and black populations, and an approximately 10-year life expectancy after diagnosis in the United States. Advances in imaging technology, with multi-slice CTs, high-resolution 3T MRIs, and state-of-the-art CT, MRI, and PET/CT techniques, have revolutionized the diagnosis of musculoskeletal disorders, including MM, and created new opportunities for improved patient care. New imaging techniques have made it possible to predict disease processes. Modern imaging has enabled the early diagnosis and treatment of patients with MM.

This field has already changed and will continue to change with the emergence of novel approaches such as radiomics, machine learning, and quantitative analysis using multiparametric imaging. All these new emerging diagnostic approaches are advocating the idea of precision and personalized medicine. This Special Issue will provide updates on novel diagnostic approaches for imaging in patients with MM.

Dr. Majid Chalian
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • PET/CT
  • MRI
  • multiple myeloma
  • diagnosis
  • multiparametric imaging

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

11 pages, 423 KiB  
Review
Illuminating the Shadows: Innovation in Advanced Imaging Techniques for Myeloma Precursor Conditions
by Kara I. Cicero, Rahul Banerjee, Mary Kwok, Danai Dima, Andrew J. Portuguese, Delphine Chen, Majid Chalian and Andrew J. Cowan
Diagnostics 2025, 15(2), 215; https://doi.org/10.3390/diagnostics15020215 - 18 Jan 2025
Viewed by 576
Abstract
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM), the asymptomatic precursors to multiple myeloma, affect up to 5% of the population over the age of 40. Bone involvement, a myeloma-defining event, represents a major source of morbidity for patients. Key [...] Read more.
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM), the asymptomatic precursors to multiple myeloma, affect up to 5% of the population over the age of 40. Bone involvement, a myeloma-defining event, represents a major source of morbidity for patients. Key goals for the management of myeloma precursor conditions include (1) identifying patients at the highest risk for progression to MM with bone involvement and (2) differentiating precursor states from active myeloma requiring treatment. Computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET)-CT with [18F]fluorodeoxyglucose (FDG) have improved sensitivity for the detection of myeloma bone disease compared to traditional skeletal surveys, and such advanced imaging also provides this field with better tools for detecting early signs of progression. Herein, we review the data supporting the use of advanced imaging for both diagnostics and prognostication in myeloma precursor conditions. Full article
(This article belongs to the Special Issue Advances in Multiple Myeloma Imaging in 2025)
Show Figures

Figure 1

Back to TopTop